Double-blind, Multicenter Trial Comparing Acetyl L-carnitine With Placebo In The Treatment Of Fibromyalgia Patients
Notes for this study:
|Number of Subjects
1g of Acetyl-L-Carnitine (ALCAR), divided into two 500mg dosages, was associated with significant improvements in symptoms of fibromyalgia relative to placebo. Specifically, there was no difference up to 6 weeks of treatment, but then the group consuming ALCAR started to experience more benefits than placebo.
These results suggest chronic ALCAR supplementation may be of use to manage symptoms of fibromyalgia.